Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Seibyl is active.

Publication


Featured researches published by John Seibyl.


Society of Nuclear Medicine Annual Meeting Abstracts | 2012

Imaging acetylcholine effects on [123I]5IA-85380 binding to beta2-nicotinic acetylcholine receptors: Physostigmine studies in human subjects

Irina Esterlis; Jonas Hannestad; Frederic Bois; John Seibyl; Marc Laruelle; Richard Carson; Kelly P. Cosgrove


Publisher | 2015

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer disease: Phase 3 study

Osama Sabri; Marwan N. Sabbagh; John Seibyl; Henryk Barthel; Hiroyasu Akatsu; Yasuomi Ouchi; Kohei Senda; Shigeo Murayama; Kenji Ishii; Masaki Takao; Thomas G. Beach; Christopher Rowe; James B. Leverenz; Bernardino Ghetti; James Ironside; Ana M. Catafau; Andrew Stephens; Andre Mueller; Norman Koglin; Anja Hoffman; Katrin Roth; Cornelia Reininger; Walter Schulz-Schaeffer


Society of Nuclear Medicine Annual Meeting Abstracts | 2013

Accuracy of DaTscan™ (Ioflupane I 123 Injection) in diagnosis of early parkinsonian syndromes (PS)

John Seibyl; Donald G. Grosset; Nin Bajaj; Robert A. Hauser; Kenneth Marek; Igor Grachev


Society of Nuclear Medicine Annual Meeting Abstracts | 2013

Age-dependent 18-F florbetaben brain PET uptake in adults with Down's syndrome

John Seibyl; Marwan N. Sabbagh; David Russell; Kenneth Marek; Andrew Stephens; Cornelia Reininger; Danna Jennings


Archive | 2013

Within assay Between assay Within assay Between assay

Richard Margolin; Nzeera Ketter; Spencer Guthrie; Denise Deegan; Linda Baher; Renee Tschopp; Kenneth Marek; John Seibyl; Johannes Streffer; Bradley T. Wyman; Kevin Booth; Eric Yuen; Daniel Gennevois; Enchi Liu; Alzheimer Immunotherapy


Society of Nuclear Medicine Annual Meeting Abstracts | 2012

Effect of imaging duration on SUV and SUVR calculations in clinical trials using beta-amyloid PET agents

Gary Winsniewski; Jeffery Batis; Olivier Barret; Valerie Iannucci; George Zubal; John Seibyl


Society of Nuclear Medicine Annual Meeting Abstracts | 2012

Validation of MNI420, a novel adenosine A2a SPECT receptor radioligand in human

Jeffery Batis; Olivier Barret; Danna Jennings; David Russell; Christine Vala; David Alagille; Ronald M. Baldwin; Ken Marek; John Seibyl; Gilles Tamagnan


Archive | 2012

Molecular Imaging in Parkinson Disease

Danna Jennings; David Russell; Ken Marek; John Seibyl


Archive | 2003

Method of determining the activity of a central nervous system drug on striatal dopamine transporter populations

Peter J. Snyder; Robert B. Innis; John Seibyl; Akira Kugaya; Stephen A. Williams


Archive | 2000

Rapid Communication Age-related decline in central serotonin transporter availability with ( 123 I)b-CIT SPECT <

Christopher H. van Dyck; Robert T. Malison; John Seibyl; Marc Laruelle; Heide Klumpp; Sami S. Zoghbi; Ronald M. Baldwin; Robert Innis

Collaboration


Dive into the John Seibyl's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Russell

Visiting Nurse Service of New York

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Stephens

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ken Marek

Georgetown University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marwan N. Sabbagh

Barrow Neurological Institute

View shared research outputs
Top Co-Authors

Avatar

Robert Innis

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge